Search results
Capturing the genAI boom for drug development
Pharmaceutical Technology· 6 days agoSanofi follows closely behind, having agreed to part with a potential $140m to work with Paris-based Aqemia – which uses genAI and deep physics...
Alumis cuts IPO size, but nets $250M for immune drug work
BioPharma Dive· 5 days agoAlumis’ public offering comes during an uptick in interest in immune drugs. Still, the company sold...
